SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Aichhorn, W.
Right arrow Articles by Whitworth, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aichhorn, W.
Right arrow Articles by Whitworth, A. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Risperidone and breast-feeding

W. Aichhorn

Department of Psychiatry, University of Innsbruck, Innsbruck, Austria, wolfgang.aichhorn{at}uibk.ac.at

C. Stuppaeck

Department of Psychiatry, PMU Salzburg, Salzburg, Austria

A. B. Whitworth

Department of Psychiatry, PMU Salzburg, Salzburg, Austria

We present the case of a breast-feeding woman with acute psychotic symptoms after delivery, which were treated with the antipsychotic agent risperidone. Serum levels of risperidone and 9-hydroxyrisperidone could be detected in both the mother and her infant. Drug-levels in breast milk were ten-fold lower compared to maternal serum. The patient responded well to antipsychotic treatment. Her infant did not display any adverse effects and psychomotor development was normal. In this case, risperidone was a safe treatment option for the breast-feeding mother and her infant. We also provide a brief overview of the clinically relevant data concerning antipsychotics and breast-feeding.

Key Words: antipsychotics • breast-feeding • risperidone

Journal of Psychopharmacology, Vol. 19, No. 2, 211-213 (2005)
DOI: 10.1177/0269881105049044
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
A. Whitworth, C. Stuppaeck, K. Yazdi, K. Kralovec, C. Geretsegger, G. Zernig, and W. Aichhorn
Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months
J Psychopharmacol, January 1, 2010; 24(1): 121 - 123.
[Abstract] [PDF]

Home page
 J Hum LactHome page
A. Parashar, A. Varma, and B. Sharp
Risperidone as Galactagogue?
J Hum Lact, May 1, 2007; 23(2): 143 - 143.
[PDF]

Home page
 Am. J. PsychiatryHome page
D. Yaeger, H. G. Smith, and L. L. Altshuler
Atypical Antipsychotics in the Treatment of Schizophrenia During Pregnancy and the Postpartum
Am J Psychiatry, December 1, 2006; 163(12): 2064 - 2070.
[Full Text] [PDF]


Advertisement